wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38104808-10BB5BF6-EC07-4127-A2B7-D1E7710F6A4D
Q38104808-10BB5BF6-EC07-4127-A2B7-D1E7710F6A4D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38104808-10BB5BF6-EC07-4127-A2B7-D1E7710F6A4D
Waldenström macroglobulinaemia: the key questions.
P2860
Q38104808-10BB5BF6-EC07-4127-A2B7-D1E7710F6A4D
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38104808-10BB5BF6-EC07-4127-A2B7-D1E7710F6A4D
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
427f10d2185135135d8bd463f3a08cc31a4d9e15
P2860
Phase II trial of weekly bortezomib in combination with rituximab in relapsed or relapsed and refractory Waldenstrom macroglobulinemia